Similar Articles
351 Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
352 Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations
353 Prevention of malignant digestive system tumors should focus on the control of chronic inflammation
354 Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
355 Systemic treatment for unresectable hepatocellular carcinoma
356 Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
357 Predictors of early and late hepatocellular carcinoma recurrence
358 Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin
359 Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
360 Current status and prospect of treatments for recurrent hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA